Trade TVGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Tevogen Inc. (TVGN) is trading at US$6.66, up 0.92% today as of Oct 6, 15:47 EDT. The company has a market capitalisation of US$43.95M. Over the past 52 weeks, TVGN has traded between US$3.64 and US$39.00. On Syfe you can trade TVGN with $0 commission and add it to your watchlist.
| Previous close | US$6.60 |
|---|---|
| Market cap | US$43.95M |
| 52-week range | US$3.64 – US$39.00 |
| Volume | 3.05K |
| Exchange | US |
Tevogen Inc.
Tevogen, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.
Year: 2024
Tevogen Bio Signs LOI to Assess Potential Acquisition of Management Services Organization
May 21, 4:40 PM · MT Newswires
Tevogen Inc. (TVGN) stock is trading at US$6.66, +0.92% from the previous close of US$6.60.
The market cap for Tevogen Inc. (TVGN) stock is approximately US$43.95M.
The 52-week high for Tevogen Inc. (TVGN) stock is US$39.00.
The 52-week low for Tevogen Inc. (TVGN) stock is US$3.64.
Tevogen Inc. (TVGN) does not currently pay a dividend.
Stay on top of TVGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
